About Medical Marijuana New York
In recent New York cannabis reform, Assembly Bill 7795 permits pharmacists to act as practitioners, certifying them to consult and recommend medical cannabis treatment options to new patients within the dispensing facility they work for.
Additionally, Assembly Bill 7826 establishes reciprocity for out-of-state medical cannabis patients, allowing qualified patients from other states to participate in New York’s medical cannabis program. Visiting patients with valid medical cannabis recommendations will be allowed to purchase medical cannabis from dispensaries within the state, and may use their medicine in accordance with local laws.
The Big Apple and the rest of the Empire State took its first bite of medical cannabis in 2014 when Gov. Andrew Cuomo signed legislation into law. Ever since Gov. Cuomo has gone above and beyond attempting to legalize cannabis recreationally, even having a Pot Summit in 2019 with other East Coast governors.
In 2018, Gov. Cuomo added PTSD to the list of conditions, and in 2018, allowed medical cannabis to be used for opioid use disorder. As far as Gov. Cuomo is concerned, recreational cannabis would answer a lot of woes along with benefiting the physical wellbeing of thousands of citizens who suffer from a list of the state’s qualifying conditions. The second benefit recreational cannabis would bring in is up to 1.3 billion dollars in tax revenue, a number Cuomo predicted for 2019 to no avail.
On May 3, 2019, the New York State Department of Health (NYSDOH) released guidelines for laboratory testing on packaged medical cannabis products. The products to be tested include capsules, pills, oral sprays, powders, tinctures, topical lotions, vape cartridges, cannabis flower, and more. These products are tested for cannabinoid potency, product stability, bacteria, mycotoxins, and containments through labs accredited through New York. This is big news because testing confirms the safety of medical cannabis products for patients.
In September of 2020, New York released guidance for medical cannabis program research that is being done in the state, which now can occur with Institutional Review Board (IRB) approval. This applied to both privately funded and federally funded cannabis research.
In March of 2021, Gov. Cuomo signed the Marijuana Taxation and Regulation Act into law, though recreational sales are at least a year out. The law allows people over the age of 21 to possess, obtain, purchase or transport up to three ounces of cannabis. It will apply a 13% tax on retail sales that won’t take effect until April 1, 2023.
Recreational marijuana sales are anticipated to begin in 2023, but no dates have been formally set.
New York will also begin regulating hemp-based products, requiring these products to adhere to particular standards including, labeling, testing, and manufacturing rules
The Site Trusted by Millions of Medical Marijuana Patients
No risk guarantee - get approved or your money back!
Intuitive online platform with 24/7 support
Appointments available on demand
Pre-qualify in under 5 minutes